Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada

Virus Research

Volumn 129, Issue 2, 2007, Pages 228-235

  Nagarajan, Malliga M ^a   Simard, Carole ^a  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

CTL epitopes; EIAV detection; Gag genetic heterogeneity; Phylogenetic analysis

Indexed keywords

GAG PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANADA; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; GENETIC HETEROGENEITY; HORSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CANADA; EQUINE INFECTIOUS ANEMIA; GENE PRODUCTS, GAG; GENES, GAG; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VARIATION (GENETICS);

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS;

EID: 35348939660     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.07.013     Document Type: Article

References (29)

1. Chiu I.-M., Yaniv A., Dahlberg J.E., Gazit A., Skuntz S.F., Tronick S.R., and Aaronson S.A. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature 317 (1985) 366-368
2. Chong Y.H., Payne S.L., Issel C.J., Montelaro R.C., and Rushlow K.E. Characterization of the antigenic domains of the major core protein (P26) of equine infectious anemia virus. J. Virol. 65 (1991) 1007-1012
3. Chung C., Mealey R.H., and McGuire T.C. Evaluation of high functional avidity CTL to Gag epitopes clusters in EIAV carrier horses. Virology 342 (2005) 228-239
4. Chung C., Mealey R.H., and McGuire T.C. CTL from EIAV carrier horses with diverse MHC class I alleles recognize clusters in Gag matrix and capsid proteins. Virology 327 (2004) 144-154
5. Coggins L., Narcross N.L., and Nusbaum S.R. Diagnosis of equine infectious anemia virus by immunodiffusion test. Am. J. Vet. Res. 33 (1972) 11-18
6. Craigo J.K., Li F., Steckbeck J.D., Durkin S., Howe L., Cook S.J., Issel C., and Montelaro R.C. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficiency. J. Virol. 79 (2005) 2666-2677
7. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., and Montelaro R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71 (1997) 3840-3852
8. Issel C.J., Adams W.V., Meek L., and Ochoa R. Transmission of equine infectious anemia virus from horses without clinical signs of disease. J. Am. Vet. Med. Assoc. 180 (1982) 272-275
9. Kono Y., Hirasawa K., Fukunaga Y., and Taniguchi T. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Q. 16 (1976) 8-15
10. Liang H., He X., Shen R.X., Shen T., Tong X., Ma Y., Xiang W.H., Zhang X.Y., and Shao Y.M. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV. Arch. Virol. 151 (2006) 1387-1403
11. Li F., Craigo J.K., Steckbeck J.D., Cook S., and Issel C. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J. Virol. 77 (2003) 7244-7253
12. Lonning S.M., Zhang W., and McGuire T.C. Gag protein epitopes recognized by CD4+ T helper lymphocytes from equine-infectious anemia virus-infected carrier horses. J. Virol. 73 (1999) 4257-4265
13. Marlowe N., Flys T., Hackett Jr. J., Schumaker M., Jackson J.B., and Eshleman S.H. Analysis of insertions and deletions in the gag p6 region of diverse HIV Type I strains. AIDS Res. Hum. Retroviruses 20 (2004) 1119-1125
14. McCormack G.P., Glynn J.R., Crewley J.P., Cramplin A.C., Travers S.A., Redmond N., Keane T.M., Siband F., Mulawa D., and Fine P.E. Emergence of a three codon deletion in gag p17 in Type I subtype C, long-term survivors, and general population spread. AIDS Res. Hum. Retroviruses 22 (2006) 195-220
15. McGuire T.C., Leib S., Mealey R.H., Fraser D.G., and Prieur D.J. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. J. Immunol. 171 (2003) 1984-1993
16. McGuire T.C., Fraser D.G., and Mealey R.H. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus. Viral Immunol. 15 (2002) 521-531
17. McGuire T.C., Leib S.R., Lonning S.M., Zhang W., Byrne K.M., and Mealey R.H. Equine infectious anemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J. Gen. Virol. 81 (2000) 2735-2739
18. McGuire T.C., Tumas D.B., Byrne K.M., Hines M., Lieb S.R., Brassfield A.L., O'Rourke K.I., and Perryman L.E. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68 (1994) 1459-1467
19. Montelaro R.C., Ball J.M., and Rushlow K.E. Equine retroviruses. In: Levy J. (Ed). The Retroviridae vol. 2 (1993), Plenum, New York 257-360
20. Nagarajan M.M., and Simard C. Detection of horses infected naturally with equine infectious anemia virus by nested polymerase reaction. J. Virol. Methods 94 (2001) 97-109
21. Paré J., and Simard C. Comparison of commercial enzyme-linked immunosorbent assays and agar gel immuno diffusion test for the serodiagnosis of equine infectious virus. Can. J. Vet. Res. 68 (2004) 254-258
22. Quinlivan M., Cook R.F., and Cullinane A. Real-time quantitative RT-PCR and PCR assays for a novel European field isolate of equine infectious anemia virus based on sequence determination of the gag gene. Vet. Rec. 160 (2007) 611-618
23. Saitou N., and Nei M. The neighbor joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
24. Soutullo A., Garcia M.I., Bailat A., Racca A., Tonarelli G., and Borel M.I. Antibodies and PBMC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides. Vet. Immunol. Immunopathol. 108 (2005) 335-343
25. Stephens R.M., Casey J.W., and Rice N.R. Equine infectious anemia virus gag and pol genes: relatedness to Visna and AIDS virus. Science 231 (1986) 589-594
26. Wang L., Tong G.Z., Liu H.Q., Yang Z.B., Kong X.Z., and Wang M. Proviral genomic analysis of equine infectious anemia virus donkey leukocyte attenuated vaccine and its parental wild type strain Liaoning. Sci. China 45 (2001) 57-67
27. Zhang W., Lonning S.M., and McGuire T.C. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J. Virol. 72 (1998) 9612-9620
28. Zhang W., Auyong D.B., Oaks L., and McGuire T.C. Natural variation of equine infectious anemia virus gag protein cytotoxic T lymphocyte epitopes. Virology 261 (1999) 242-252
29. Zhang X.Y., Li H.M., Liang H., Shen T., Ma Y., Xiang W.H., Shen R.X., and Shao Y.M. Induction of EIAV-specific cellular immune response by attenuated EIAV vaccine. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22 (2006) 115-118